Home World News Arsenic Trioxide in Combination with All-Trans Retinoic Acid for the Treatment of... World News Arsenic Trioxide in Combination with All-Trans Retinoic Acid for the Treatment of Newly Diagnosed Patients with High-Risk APL By Ogkologos - September 3, 2025 610 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the APOLLO study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR FDA Approves Alectinib as Adjuvant Treatment for ALK-positive Non-Small Cell Lung... April 25, 2024 Into the archives: the story of HPV and cervical cancer November 21, 2022 EMA Recommends Extension of Therapeutic Indications for Trifluridine/Tipiracil July 7, 2023 EMA Recommends Granting a Marketing Authorisation for Tebentafusp March 31, 2022 Load more HOT NEWS No Improvement in OS or PFS from Sacituzumab Govitecan Compared with... FDA Grants Accelerated Approval to Umbralisib for Marginal Zone and Follicular... Beloved Kansas City Jazz Singer Passes Away at 48 After 13-Year... Reduction Not Only in Recurrences, but Also in Mortality, Observed for...
